TOCQUEVILLE ASSET MANAGEMENT L.P. - REGULUS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$374,000
-43.3%
113,250
-50.4%
0.00%0.0%
Q2 2016$660,000
-28.6%
228,300
+71.1%
0.00%
-66.7%
Q1 2016$925,000
-22.7%
133,450
-2.8%
0.01%
-25.0%
Q4 2015$1,197,000
+29.8%
137,250
-2.6%
0.02%
+33.3%
Q3 2015$922,000
+88.2%
140,950
+215.3%
0.01%
+100.0%
Q2 2015$490,000
+3.6%
44,700
+60.2%
0.01%0.0%
Q1 2015$473,000
-25.5%
27,900
-29.5%
0.01%
-14.3%
Q4 2014$635,000
+15.2%
39,600
-42.2%
0.01%
+40.0%
Q2 2014$551,000
-4.5%
68,500
+7.0%
0.01%
-37.5%
Q1 2014$577,000
+116.9%
64,000
+77.8%
0.01%
+100.0%
Q4 2013$266,000
-8.9%
36,000
+16.1%
0.00%0.0%
Q3 2013$292,00031,0000.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 4,039,823$26,420,0003.79%
Foresite Capital Management II, LLC 1,750,269$11,447,0003.48%
ARGONAUT CAPITAL MANAGEMENT CORP 75,000$491,0001.65%
Abingworth LLP 327,350$2,138,0001.25%
Trellus Management Company, LLC 100,000$654,0000.96%
Cormorant Asset Management, LP 896,522$5,863,0000.94%
DAFNA Capital Management LLC 90,000$589,0000.58%
ORACLE INVESTMENT MANAGEMENT INC 749,064$4,898,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
View complete list of REGULUS THERAPEUTICS INC shareholders